Annual Meeting

Stressed out? The cancer playbook may help

Learn about the session on stress adaptations in tumor progression in the Maximizing Access Committee’s symposium at Discover BMB 2024
Jonathan A. Kelber
By Jonathan A. Kelber
Sept. 14, 2023

We often associate the concept of stress with deadlines, emergencies, traffic or hardships. For those who study biological and biochemical processes of disease in cell and organismal models, the idea of stress adaptation is recognized as one mechanism by which malignant and nonmalignant cells survive and thrive within environments that, at times, are hostile.

Are there ways that we think about environmental stress adaptations at an organismal level that may help scientists develop new perspectives on combatting cancer to improve patient outcomes? Indeed, cancer cells may even engage in molecular decision-making activities that differentiate between fight-or-flight responses in the face of environmental stress.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

This session will consider the mechanisms by which cancer cells adapt to intrinsic and extrinsic stressors and how defining these adaptative mechanisms may lead to improved treatment strategies. Topics will include nutrient access/use, aging, subcellular compartments, microenvironmental influences and tissue reprogramming.

Keywords: Cancer biology, molecular crosstalk, biochemical signaling, tissue homeostasis, aging, subcellular transport, local and global adaptations, tumor microenvironment.

Who should attend: Cancer researchers, cell biologists and biochemists interested in considering how aging, biochemistry and multi-scale adaptations cooperate to shape the stress landscapes of tumors.

Theme song: “Stressed Out” by A Tribe Called Quest

This session is powered by cortisol and catecholamines.

Stress adaptations in tumor progression

Jonathan Kelber (chair), Baylor University

Elda GrabockaThomas Jefferson University

Christina TowersSalk Institute for Biological Studies

Mark LaBargeBeckman Research Institute of City of Hope

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jonathan A. Kelber
Jonathan A. Kelber

Jonathan A. Kelber is an associate professor of biology at Baylor University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How sugars shape Marfan syndrome
Journal News

How sugars shape Marfan syndrome

Sept. 10, 2025

Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.